Search Results for ''

published presentations and documents on DocSlides.

Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies

Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies

by SugarPlumFairy

FDA Perspective. Marco Cannella, PhD. Senior Lead ...

FDA Regulatory Requirements for Successful Biomarker Applications

FDA Regulatory Requirements for Successful Biomarker Applications

by oliver

Early Detection Research Network. September 9, 201...

6/14/2012 FDA/CVM 1 Tong Zhou, Ph.D., DABT

6/14/2012 FDA/CVM 1 Tong Zhou, Ph.D., DABT

by myesha-ticknor

Division of Human Food Safety. Office of New Anim...

1 FDA’s BIMO Inspection Program

1 FDA’s BIMO Inspection Program

by olivia-moreira

and. IRB Inspections. VA IRB Chairs Meeting. Aug...

FDA Regulation of Menthol in Tobacco Products

FDA Regulation of Menthol in Tobacco Products

by pamella-moone

Patricia Kovacevic. Director, Regulatory . Aff...

Perspectives on the Animal Rule

Perspectives on the Animal Rule

by mia

What is the Animal Rule?. The Basics. J.E. Estep, ...

Karen Davis-Bruno Ph.D (FDA/CDER/OND)

Karen Davis-Bruno Ph.D (FDA/CDER/OND)

by isabella2

Melissa Tassinari . Ph.D. (FDA/CDER/OND/DPMH). Jac...

Guidance for Clinical Investigators Sponsors and Investigational New D

Guidance for Clinical Investigators Sponsors and Investigational New D

by jade

NOTE A stay is in effect for partsof subsection V...

It is the policy of the University of Arkansas for Med

It is the policy of the University of Arkansas for Med

by ellena-manuel

All individuals who are in a position to con...

Safety of food additives: The regulatory Roadmap

Safety of food additives: The regulatory Roadmap

by kittie-lecroy

Manojit Basu, PhD . Grocery Manufacturers Associa...

Safety of food additives: The regulatory Roadmap

Safety of food additives: The regulatory Roadmap

by mitsue-stanley

Manojit Basu, PhD . Grocery Manufacturers Associa...

FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events

FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events

by lois-ondreau

S. Percy Ivy, MD. Associate Chief, Senior Investi...

1 Structure and mandate of FDA

1 Structure and mandate of FDA

by sherrill-nordquist

Leonard Sacks. Office of Medical Policy. CDER, FD...

substance shall be

substance shall be

by alis

BLA 761156 months from the date of manufacture whe...

Reynolds American Inc

Reynolds American Inc

by jalin

P.O. Box 2990 Winston - Salem, NC 27102 - 2990 Me...

Assessing and Monitoring for Intravascular Injections

Assessing and Monitoring for Intravascular Injections

by nicole

Henry Lee, MD. Office of Health Technology 4: Surg...

Al Crouse, CVRx ; Owen Faris, FDA; Ravi Nabar, Illumina;

Al Crouse, CVRx ; Owen Faris, FDA; Ravi Nabar, Illumina;

by adia

Joseph Sapiente, MDIC; Sara Sulfridge, Baxter. Apr...

TABLE OF CONTENTS

TABLE OF CONTENTS

by tracy

I. INTRODUCTION .....................................

Dosage Form Design Chapter 1

Dosage Form Design Chapter 1

by scarlett

Dr. . . Athmar. . Dhahir. Habeeb. PhD in Industr...

Jean L. Patterson, Ph.D.

Jean L. Patterson, Ph.D.

by alida-meadow

Chair, Department of . Virology. and Immunology....

Nor Cal SOT Evaluation of Carcinogenic Risk for Biotechnology-Derived Therapeutics

Nor Cal SOT Evaluation of Carcinogenic Risk for Biotechnology-Derived Therapeutics

by danika-pritchard

Nor Cal SOT Evaluation of Carcinogenic Risk for B...

Regulatory Toxicology Presentation

Regulatory Toxicology Presentation

by marina-yarberry

Overview. Overview. . of. . the. . Food. . an...

Minor Use Minor Species (MUMS)

Minor Use Minor Species (MUMS)

by faustina-dinatale

Grants . Meg Oeller & Stuart Jeffrey FDA/...

Antibacterial Soaps:

Antibacterial Soaps:

by lindy-dunigan

Are they Necessary?. Sarah Janssen, M.D., Ph.D., ...

by giovanna-bartolotta

Risk. and . Antidepressants. Background. The War...

Antibacterial Soaps:

Antibacterial Soaps:

by conchita-marotz

Are they Necessary?. Sarah Janssen, M.D., Ph.D., ...

SEND Submissions – Quality review by QA – Yes/No?

SEND Submissions – Quality review by QA – Yes/No?

by danika-pritchard

Daniel Potenta, Michael Wasko, Nina . Häuselmann...

Stendra Ejaculation

Stendra Ejaculation

by liane-varnes

Het is nog veel te leuk om recepten en mooie foto...

State of the Art in BRCA

State of the Art in BRCA

by ellena-manuel

-Mutated Ovarian Cancer. This program will includ...

What is Real & Nutritious Food:

What is Real & Nutritious Food:

by briana-ranney

What about Food Additives?. Lisa Y. Lefferts, MSP...

Extrapolation in Pediatric Drug Development: An Evolving Science

Extrapolation in Pediatric Drug Development: An Evolving Science

by briana-ranney

Lynne P. Yao, M.D.. Director, Division of Pediatr...

Regulatory issues in HIV cure Research

Regulatory issues in HIV cure Research

by debby-jeon

HIV Cure Research Training Curriculum. Regulatory...

A Look Back on Diabetes in 2015 to Look Forward in 2016

A Look Back on Diabetes in 2015 to Look Forward in 2016

by conchita-marotz

A Look Back on Diabetes in 2015 to Look Forward i...

Copyrighted 2013 BIMO Checklist Joyce Nancarrow Tull

Copyrighted 2013 BIMO Checklist Joyce Nancarrow Tull

by eleanor

1FDA Bioresearch Monitoring BIMO ChecklistRegulati...

EALTH 145 1 Copyright 2007 Maureen C Kelley and Samuel J Tilden

EALTH 145 1 Copyright 2007 Maureen C Kelley and Samuel J Tilden

by violet

4.26.08 4/26/20085:44:01PM VERSIGHT OF HANGES AND...

Vernon D. Toelle, Ph.D. Team Leader

Vernon D. Toelle, Ph.D. Team Leader

by ani

Pre-Market Compliance and . Administrative Actions...

Neurodevelopmental Impact of Anesthetics in Pediatric Patients: 2019 Update

Neurodevelopmental Impact of Anesthetics in Pediatric Patients: 2019 Update

by gabriella

Zhe. Chen, MD . Assistant Clinical Professor . An...